Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Graham, H.Kerr
2000.
Botulinum toxin A in cerebral palsy: Functional outcomes.
The Journal of Pediatrics,
Vol. 137,
Issue. 3,
p.
300.
Boyd, R. N.
Dobson, F.
Parrott, J.
Love, S.
Oates, J.
Larson, A.
Burchall, G.
Chondros, P.
Carlin, J.
Nattrass, G.
and
Graham, H. K.
2001.
The effect of botulinum toxin type A and a variable hip abduction orthosis on gross motor function: a randomized controlled trial.
European Journal of Neurology,
Vol. 8,
Issue. s5,
p.
109.
Jankovic, Joseph
and
Tintner, Ron
2001.
Botulinum toxin for the treatment of cervical dystonia.
Expert Opinion on Pharmacotherapy,
Vol. 2,
Issue. 12,
p.
1985.
Chalkiadis, George A
2001.
Management of chronic pain in children.
Medical Journal of Australia,
Vol. 175,
Issue. 9,
p.
476.
Gormley Jr., M. E.
Krach, L. E.
and
Piccini, L.
2001.
Spasticity management in the child with spastic quadriplegia.
European Journal of Neurology,
Vol. 8,
Issue. s5,
p.
127.
Boyd, R. N.
and
Hays, R. M.
2001.
Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review.
European Journal of Neurology,
Vol. 8,
Issue. s5,
p.
1.
Tintner, Ron
and
Jankovic, Joseph
2001.
Focal dystonia: The role of botulinum toxin.
Current Neurology and Neuroscience Reports,
Vol. 1,
Issue. 4,
p.
337.
Lang, Amy M.
2002.
Botulinum Toxin therapy for myofascial pain disorders.
Current Pain and Headache Reports,
Vol. 6,
Issue. 5,
p.
355.
Evers, S
Rahmann, A
Vollmer-Haase, J
and
Husstedt, I-W
2002.
Treatment of Headache with Botulinum Toxin A—a Review According To Evidence-Based Medicine Criteria.
Cephalalgia,
Vol. 22,
Issue. 9,
p.
699.
Metaxiotis, Dimitrios
Siebel, Andrea
and
Doederlein, Leonhard
2002.
Repeated Botulinum Toxin A Injections in the Treatment of Spastic Equinus Foot.
Clinical Orthopaedics and Related Research,
Vol. 394,
Issue. ,
p.
177.
Carrelet, P
Bollini, G
Mancini, J
and
Chabrol, B
2002.
Traitement de l'enfant infirme moteur cérébral par la toxine botulique A : mode d'action, place des injections dans la prise en charge.
Archives de Pédiatrie,
Vol. 9,
Issue. 9,
p.
928.
WONGPRASARTSUK, PORANEE
and
STEVENS, JOHN
2002.
Cerebral palsy and anaesthesia.
Pediatric Anesthesia,
Vol. 12,
Issue. 4,
p.
296.
Flett, PJ
2003.
Rehabilitation of spasticity and related problems in childhood cerebral palsy.
Journal of Paediatrics and Child Health,
Vol. 39,
Issue. 1,
p.
6.
Tilton, Ann H.
2003.
Injectable Neuromuscular Blockade in the Treatment of Spasticity and Movement Disorders.
Journal of Child Neurology,
Vol. 18,
Issue. 1_suppl,
p.
S50.
Delgado, Mauricio R.
2003.
Botulinum Neurotoxin Type A.
Journal of the American Academy of Orthopaedic Surgeons,
Vol. 11,
Issue. 5,
p.
291.
Ehde, Dawn M.
Jensen, Mark P.
Engel, Joyce M.
Turner, Judith A.
Hoffman, Amy J.
and
Cardenas, Diana D.
2003.
Chronic Pain Secondary to Disability: A Review.
The Clinical Journal of Pain,
Vol. 19,
Issue. 1,
p.
3.
Mooney,, James F.
Koman, L. Andrew
and
Smith, Beth P.
2003.
Pharmacologic Management of Spasticity in Cerebral Palsy.
Journal of Pediatric Orthopaedics,
p.
679.
Mooney,, James F.
Koman, L. Andrew
and
Smith, Beth P.
2003.
Pharmacologic Management of Spasticity in Cerebral Palsy.
Journal of Pediatric Orthopaedics,
Vol. 23,
Issue. 5,
p.
679.
Chin, Terence Y.P
and
Graham, H.Kerr
2003.
Botulinum toxin A in the management of upper limb spasticity in cerebral palsy.
Hand Clinics,
Vol. 19,
Issue. 4,
p.
591.
Zernikow, B.
Dietz, B.
Hafkemeier, U.
and
Kluger, G.
2003.
Schmerztherapie bei Kindern.
p.
361.